Sophie Graham and Jennifer Burgess explore the associations between persistent and severe postnatal depression in mothers and mental health and educational outcomes in their offspring.
[read the full story...]
Dean Connolly presents the findings of a recent literature review on chemsex, which explores sexualised drug use in UK men who have sex with men.
[read the full story...]
Thomas Richardson looks at a recent prospective cohort study in the British Journal of Psychiatry on adolescent cannabis use, baseline prodromal symptoms and the risk of psychosis.
[read the full story...]
Eleanor Kennedy summarises a Danish observational cohort study, which looks at the long-term risk of dementia among people with traumatic brain injury.
[read the full story...]
Josefien Breedvelt explores a brand new review looking at preventive strategies for mental health problems, published yesterday in The Lancet Psychiatry.
[read the full story...]
Elwira Lubos summarises a recent review of reviews looking at the evidence for improving outcomes in first-episode psychosis.
[read the full story...]
Sally Adams summarises a recent clinical review in Evidence Based Mental Health on the effects of drinking alcohol on late-life brain and cognition.
Follow #EBMHchat today from 3pm for an expert Google Hangout on this paper.
[read the full story...]
This review of the association of Vitamin D and periodontal disease identified 27 mainly observational studies providing little data to support or refute the association
[read the full story...]
Mark Edwards considers the findings of a new meta-analysis of case-control studies, which looks at the relationship between stressful life events, neglect and abuse with functional neurological disorder.
[read the full story...]
Rina Dutta and Patrick McLaughlin summarise a new study looking at the effects of SSRIs (Selective Serotonin Reuptake Inhibitors) on rating-scale-assessed suicidality in adults with depression.
This study published in the British Journal of Psychiatry supports the conclusion that SSRIs remain a safe and effective treatment in depression for those aged 18 and over.
[read the full story...]
